Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A randomised controlled trial recently published in The Lancet showed that once-weekly semaglutide - alongside CBT - reduced heavy drinking days by 50% more than placebo in patients with comorbid obesity
That includes patients with severe obesity, significant metabolic disease, or a history of losing and regaining weight repeatedly
We believe this is a high-quality, safe and effective weight loss tool
High-dose users (12.5 to 15mg) should commit to a full 30-day washout, possibly extending to 35 days if they experienced significant GI side effects on tirzepatide
US$ 20.28
US$ 24.64
US$ 26.37
US$ 26.16
US$ 29.91
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
